EUSA Pharma Gains Foothold In U.S. Market With Cytogen Acquisition
This article was originally published in The Pink Sheet Daily
Executive Summary
Buyout positions U.K. drug maker to take on new licensing deals on both sides of the Atlantic; oncology filing planned within 12 months, EUSA tells the DAILY.